Literature DB >> 20478936

Defensin-barbed innate immunity: clinical associations in the pediatric population.

Mark A Underwood1, Charles L Bevins.   

Abstract

Defensins and related antimicrobial peptides serve a central role in innate immunity in all species of plants and animals. In humans, defensins are widely expressed, including in neutrophils, skin, and mucosal epithelia. Most defensins are potent antibiotics, and some have chemotactic and toxin-neutralizing activities. Results of recent studies on the homeostatic and disease-fighting activities of human defensins point to a key relevance in several pediatric disorders. Inherited variation in defensin gene expression may contribute to susceptibility to several diseases, including psoriasis and Crohn disease. We review here the recent discoveries in innate immunity that shed light on the potential roles of defensins, and other antimicrobial molecules, in the pathophysiology of common pediatric diseases such as atopic dermatitis, necrotizing enterocolitis, cystic fibrosis, and otitis media.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478936     DOI: 10.1542/peds.2009-3289

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  19 in total

Review 1.  Immunological basis in the pathogenesis and treatment of bladder cancer.

Authors:  David B Thompson; Larry E Siref; Michael P Feloney; Ralph J Hauke; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2014-11-13       Impact factor: 4.473

2.  Specific-sized hyaluronan fragments promote expression of human β-defensin 2 in intestinal epithelium.

Authors:  David R Hill; Sean P Kessler; Hyunjin K Rho; Mary K Cowman; Carol A de la Motte
Journal:  J Biol Chem       Date:  2012-07-03       Impact factor: 5.157

3.  pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37.

Authors:  Mahmoud H Abou Alaiwa; Leah R Reznikov; Nicholas D Gansemer; Kelsey A Sheets; Alexander R Horswill; David A Stoltz; Joseph Zabner; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

4.  The correlation between the vitamin A, D, and E levels and recurrent respiratory tract infections in children of different ages.

Authors:  Wenqiu Tian; Wenxia Yi; Jing Zhang; Mei Sun; Rongrong Sun; Zhixin Yan
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

5.  β-Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN-α production by human plasmacytoid dendritic cells, and promote inflammation.

Authors:  Poonam Tewary; Gonzalo de la Rosa; Neeraj Sharma; Luis G Rodriguez; Sergey G Tarasov; O M Zack Howard; Hidekazu Shirota; Folkert Steinhagen; Dennis M Klinman; De Yang; Joost J Oppenheim
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

Review 6.  Paneth cells and necrotizing enterocolitis: a novel hypothesis for disease pathogenesis.

Authors:  Steven J McElroy; Mark A Underwood; Michael P Sherman
Journal:  Neonatology       Date:  2012-09-20       Impact factor: 4.035

Review 7.  The innate immune response during urinary tract infection and pyelonephritis.

Authors:  John David Spencer; Andrew L Schwaderer; Brian Becknell; Joshua Watson; David S Hains
Journal:  Pediatr Nephrol       Date:  2013-06-05       Impact factor: 3.714

8.  Glutamine Improves Innate Immunity and Prevents Bacterial Enteroinvasion During Parenteral Nutrition.

Authors:  Xinying Wang; Joseph F Pierre; Aaron F Heneghan; Rebecca A Busch; Kenneth A Kudsk
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-05-16       Impact factor: 4.016

Review 9.  Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism.

Authors:  Yan Campbell; Mary L Fantacone; Adrian F Gombart
Journal:  Eur J Nutr       Date:  2012-07-15       Impact factor: 5.614

10.  Safety and tolerability of low-dose naltrexone therapy in children with moderate to severe Crohn's disease: a pilot study.

Authors:  Jill P Smith; Douglas Field; Sandra I Bingaman; Robert Evans; David T Mauger
Journal:  J Clin Gastroenterol       Date:  2013-04       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.